Skip to content
About
About us
Our Mission
Leadership
Management
Board of Directors
Our Science
Pipeline
SIL-204
RNAi/siRNA
Solid Tumors
KRAS
Publication
Investors
Presentation and Events
Press releases
Corporate Governance
Filing and Finances
Stock information
Analyst Coverage
Contact us
Menu
About
About us
Our Mission
Leadership
Management
Board of Directors
Our Science
Pipeline
SIL-204
RNAi/siRNA
Solid Tumors
KRAS
Publication
Investors
Presentation and Events
Press releases
Corporate Governance
Filing and Finances
Stock information
Analyst Coverage
Contact us
Presentation and Events
Corporate Presentation – March 2025
Find Out More ⟶
Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination
Find Out More ⟶
Silexion Therapeutics Presented the LODER™ phase 2 summary results in the 2023 ESMO Immuno-Oncology Congress
Find Out More ⟶
